Jane Wright-Mitchell - 12 Aug 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
General Counsel
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
12 Aug 2021
Net transactions value
-$239,700
Form type
4
Filing time
16 Aug 2021, 16:31:24 UTC
Next filing
18 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $20,300 +10,000 +320% $2.03* 13,125 12 Aug 2021 Direct F1
transaction PCVX Common Stock Sale $260,000 -10,000 -76% $26.00 3,125 12 Aug 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -10,000 -5% $0.000000 189,968 12 Aug 2021 Common Stock 10,000 $2.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.